Company Description

NomosLogic is a clinical genomics infrastructure company building deterministic precision medicine at scale. The platform integrates 17M+ clinical assets including 496,805 variant-phenotype mappings to enable therapy selection, risk stratification, and variant interpretation across cardiovascular, oncology, neurology, rare disease, and pharmacogenomics. Core focus areas include adverse drug reaction prevention and eliminating trial-and-error prescribing